Innate immune pathways controlling IL-1beta production and adjuvant-induced T helper 17 cell differentiation
<p>Although adjuvants are critical vaccine components, their modes of action are poorly understood. This has hampered the development of novel adjuvants, and as a result there are very few approved for clinical use. Moreover, none of the clinically-approved adjuvants are able to induce T helpe...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2011
|
| Aiheet: |